TAKHZYRO was granted a contract as a subcutaneous prophylactic treatment for HAE Type I/II patients in Quebec.

The OnePath^® Patient Support Program will support in patient enrolment and training, and provide customizable program offerings to help address the needs of each physician/clinic.